Single Ascending Doses (SAD) and Multiple Ascending Doses(MAD) Study of IG001119 in Healthy Adult Participants
Clinical trial NCT07618247 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07618247
- Sponsor
- Iongen Therapeutics Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-04
- Primary completion
- 2027-04-30
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.